CORRECT ANSWERS PLUS RATIONALES
LATEST UPDATE 2026-2027 GRADED A+
97 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Synthesize subjective and objective data to formulate prioritized differential diagnoses in primary care
2 Select and interpret evidence-based screening and diagnostic tests according to current national
guidelines
3 Design safe, effective, and patient-centered pharmacologic and non-pharmacologic treatment plans
4 Apply health promotion, disease prevention, and chronic disease management strategies across diverse
populations
5 NR 511 CEA Exam Questions and Correct Answers plus Rationales Latest Update 2026
6 2027 Graded A+
7 Foundations of Primary Care Across the Lifespan - NR 511 Certified Emergency/Ambulatory (CEA)
Examination
8 Applied Primary Care Across the Lifespan - NR 511 Certified Emergency/Ambulatory (CEA) Examination
9 Advanced Primary Care Across the Lifespan - NR 511 Certified Emergency/Ambulatory (CEA)
Examination
10 Primary Care Across the Lifespan - NR 511 Certified Emergency/Ambulatory (CEA) Examination Review
ABSTRACT
This study document brings together 97 carefully worded exam questions drawn from NR 511 CEA
Exam Questions and Correct Answers plus Rationales Latest Update 2026-2027 Graded A+, with
the strongest emphasis placed on Synthesize subjective and objective data to formulate prioritized
differential diagnoses in primary care, Select and interpret evidence-based screening and
diagnostic tests according to current national guidelines, Design safe, effective and and
patient-centered pharmacologic and non-pharmacologic treatment plans. Every item follows the
wording style and level of reasoning you meet in the real paper, and each one is paired with a clear
rationale so the correct choice is never a guess. Work through the set at your own pace, mark the
questions that slow you down, then come back to them until the reasoning feels automatic.
Learners who revise this way walk into the exam room recognising the pattern behind the
questions instead of meeting them for the first time. Keep going - steady, honest practice is what
turns a difficult paper into a comfortable pass.
Page 1
,Q1 SYNTHESIZE SUBJECTIVE AND OBJECTIVE DATA TO FORMULATE PRIORITIZED
DIFFERENTIAL DIAGNOSES IN PRIMARY CARE
A patient with newly diagnosed heart failure with reduced ejection fraction (HFrEF)
and NYHA class II symptoms is initiated on guideline-directed medical therapy.
Which combination of drug classes has the strongest evidence for reducing both
mortality and hospitalizations?
A. ACE inhibitor + beta-blocker + mineralocorticoid receptor antagonist CORRECT
B. Loop diuretic + digoxin + hydralazine/isosorbide dinitrate
C. Angiotensin receptor blocker + calcium channel blocker + statin
D. Beta-blocker + ivabradine + ranolazine
RATIONALE: ACE inhibitors (or ARBs/ARNIs), evidence-based beta-blockers, and MRAs are the
cornerstone of HFrEF therapy, each with mortality benefit. Diuretics improve symptoms but not
mortality; digoxin reduces hospitalizations but not mortality. CCBs and ranolazine are not first-line
for HFrEF.
Q2 SYNTHESIZE SUBJECTIVE AND OBJECTIVE DATA TO FORMULATE PRIORITIZED
DIFFERENTIAL DIAGNOSES IN PRIMARY CARE
Which statement best reflects the 2023 ADA Standards of Care regarding
screening for type 2 diabetes in asymptomatic adults?
A. Screen all adults beginning at age 45 regardless of risk factors.
B. Screen adults with overweight/obesity and one or more risk factors, and all adults beginning
at age 35. CORRECT
C. Screen only adults with a family history of diabetes or hypertension.
D. Screen using fasting plasma glucose every 5 years for all adults.
RATIONALE: The ADA now recommends screening all adults starting at age 35 and those with
overweight/obesity plus additional risk factors, regardless of age. Universal screening at 45 is
outdated; targeted screening based solely on family history misses many cases. Fasting glucose
every 5 years is not the recommended interval.
Page 2
,Q3 SYNTHESIZE SUBJECTIVE AND OBJECTIVE DATA TO FORMULATE PRIORITIZED
DIFFERENTIAL DIAGNOSES IN PRIMARY CARE
A patient presents with acute onset of unilateral facial paralysis, inability to close
the eye, and loss of taste on the anterior tongue. Which finding would most
strongly suggest an alternative diagnosis to Bell's palsy?
A. Presence of hyperacusis
B. Involvement of only the lower face
C. Gradual onset over 2 weeks
D. Bilateral facial weakness CORRECT
RATIONALE: Bell's palsy is typically unilateral; bilateral involvement raises concern for
Guillain-Barré syndrome, Lyme disease, or sarcoidosis. Hyperacusis and anterior tongue taste
loss are common in Bell's palsy due to chorda tympani involvement. Lower face only suggests a
central (upper motor neuron) lesion. Gradual onset over weeks is atypical for Bell's palsy and
suggests tumor or other process.
Q4 SYNTHESIZE SUBJECTIVE AND OBJECTIVE DATA TO FORMULATE PRIORITIZED
DIFFERENTIAL DIAGNOSES IN PRIMARY CARE
According to the 2021 USPSTF recommendations, which strategy is recommended
for lung cancer screening in high-risk adults?
A. Annual low-dose computed tomography (LDCT) for adults aged 50-80 with a 20 pack-year
history who currently smoke or quit within the past 15 years. CORRECT
B. Annual chest X-ray for adults aged 55-74 with a 30 pack-year history.
C. Once-only LDCT for adults aged 50-80 with any smoking history.
D. Sputum cytology every 2 years for adults aged 50-80 with a 20 pack-year history.
RATIONALE: The 2021 USPSTF expanded LDCT screening to adults 50-80 with a 20 pack-year
history who currently smoke or quit within 15 years. Chest X-ray and sputum cytology are not
recommended for screening. Screening is annual, not once-only.
Page 3
, Q5 SYNTHESIZE SUBJECTIVE AND OBJECTIVE DATA TO FORMULATE PRIORITIZED
DIFFERENTIAL DIAGNOSES IN PRIMARY CARE
A patient with COPD (GOLD stage 2) reports increased dyspnea and productive
cough. Which intervention has been shown to reduce exacerbations and improve
quality of life?
A. Regular use of short-acting beta-agonists alone
B. Inhaled corticosteroids (ICS) as monotherapy
C. Long-acting beta-agonist (LABA) + long-acting muscarinic antagonist (LAMA) combination
therapy CORRECT
D. Oral theophylline as first-line maintenance
RATIONALE: LABA+LAMA combination therapy reduces exacerbations and improves lung
function and quality of life in COPD. SABA alone is for rescue. ICS monotherapy is not
recommended; ICS is added for frequent exacerbations or eosinophilic phenotype. Theophylline
has a narrow therapeutic index and is not first-line.
Q6 SYNTHESIZE SUBJECTIVE AND OBJECTIVE DATA TO FORMULATE PRIORITIZED
DIFFERENTIAL DIAGNOSES IN PRIMARY CARE
A patient with major depressive disorder has not responded to an adequate trial of
an SSRI. Which augmentation strategy has the strongest evidence for efficacy?
A. Adding a second SSRI
B. Adding bupropion or an atypical antipsychotic (e.g., aripiprazole) CORRECT
C. Switching to a monoamine oxidase inhibitor (MAOI) immediately
D. Adding a benzodiazepine
RATIONALE: Augmentation with bupropion or atypical antipsychotics (aripiprazole, quetiapine)
has robust evidence for treatment-resistant depression. Adding a second SSRI increases side
effects without added benefit. MAOIs require washout and are not immediate. Benzodiazepines
do not treat depression and carry dependence risk.
Page 4